|
Back to Home » May 2011 News » Noble Financial Initiates Equity Research Analyst Coverage on Aeolus |
Noble Financial Initiates Equity Research Analyst Coverage on Aeolus |
May 26, 2011
MISSION VIEJO, CA--(Marketwire - May 26, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) today announced that Noble Financial Group initiated equity research coverage on the Company with a "Buy" recommendation and a 12-month price target of $3.30 per share. The new report, issued this week, was authored by Nathan Cali, Senior Research Analyst, Biotechnology and Specialty Pharmaceuticals.
Source URL: http://www.marketwire.com/mw/release.do?id=1519707&sourceType=3
|
|
|
|
